CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
{{output}}
Mucopolysaccharidosis (MPS) syndromes are a group of heterogeneous genetic disorders in terms of genetic basis and clinical manifestations, ranging from mild to fatal forms. There are a number of applied or prospective treatment modalities for MPS, including b... ...